Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
The development of novel drug delivery systems for targeted cancer therapy has emerged as a promising approach to improve the efficacy and minimize the side effects of anticancer drugs. This thesis aims to explore the design, development, and evaluation of innovative drug delivery systems tailored for targeted cancer treatment. The research is motivated by the urgent need for more effective and less toxic therapies for cancer patients. The introduction provides a comprehensive overview of the current challenges in cancer treatment, emphasizing the limitations of conventional chemotherapy and the potential benefits of targeted drug delivery systems. The background of the study delves into the molecular mechanisms of cancer progression and the rationale behind targeting specific pathways for therapy. The problem statement highlights the shortcomings of existing treatment modalities and underscores the necessity for novel drug delivery approaches. The objectives of the study are to design and optimize drug delivery systems that can selectively target cancer cells while sparing healthy tissues, to evaluate the efficacy and safety of these systems in preclinical models, and to assess their potential for clinical translation. The limitations of the study are acknowledged, including the complexity of cancer biology, the heterogeneity of tumor types, and the challenges associated with scaling up experimental findings to clinical applications. The scope of the study encompasses the development of various drug delivery platforms, including nanoparticles, liposomes, micelles, and polymer-based carriers, for the targeted delivery of chemotherapeutic agents, immunotherapeutics, and gene therapies. The significance of the study lies in its potential to revolutionize cancer treatment by enhancing drug efficacy, reducing systemic toxicity, and overcoming drug resistance mechanisms. The structure of the thesis is outlined, detailing the organization of chapters and the flow of content. Definitions of key terms related to drug delivery, cancer biology, and therapeutic modalities are provided to ensure clarity and understanding throughout the thesis. The literature review critically evaluates the existing literature on targeted drug delivery systems for cancer therapy, highlighting recent advances, challenges, and future directions in the field. The research methodology section describes the experimental approaches, techniques, and assays used to design, characterize, and evaluate the drug delivery systems in preclinical models. The discussion of findings chapter presents a detailed analysis of the experimental results, including in vitro and in vivo studies, pharmacokinetic profiles, toxicity assessments, and mechanistic insights into the mode of action of the drug delivery systems. The conclusions drawn from the study underscore the potential of targeted drug delivery systems in improving cancer treatment outcomes and the need for further research to optimize their clinical utility. In summary, this thesis contributes to the growing body of knowledge on the development of novel drug delivery systems for targeted cancer therapy, offering insights into their design, characterization, efficacy, and safety profiles. The findings of this study have implications for the future of cancer treatment, paving the way for personalized and precision medicine approaches that can transform the landscape of oncology.